Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay

In Vitro Cellular and Developmental Biology - Animal

Volumn 39, Issue 1-2, 2003, Pages 36-42

  Pol, Arno ^a   Bergers, Mieke ^a   Schalkwijk, Joost ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Drug screening model; In vitro; PicoGreen; Proliferation assay; Psoriasis

Indexed keywords

5 (2 AMINO 4 PYRIMIDINYL) 4 (4 FLUOROPHENYL) 1 (4 PIPERIDINYL)IMIDAZOLE; ANTIPSORIASIS AGENT; CURCUMIN; CYCLOSPORIN A; DITHRANOL; DNA; DYE; INDOMETACIN; LACTATE DEHYDROGENASE; METHOTREXATE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; RETINOIC ACID; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DRUG EFFECT; ENZYME RELEASE; GROWTH; GROWTH INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; PSORIASIS;

ANTHRALIN; BIOLOGICAL ASSAY; CELL DIVISION; CELLS, CULTURED; CURCUMIN; CYCLOSPORINE; DERMATOLOGIC AGENTS; DNA; ENZYME INHIBITORS; FLUORESCENT DYES; HUMANS; KERATINOCYTES; METHOTREXATE; ORGANIC CHEMICALS; PROPIDIUM; PSORIASIS; TRETINOIN;

EID: 0043125910     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1290/1543-706X(2003)039<0036:COAEOE>2.0.CO;2     Document Type: Article

References (25)

1. Blaheta, R. A.; Kronenberger, B.; Woitaschek, D., et al. Development of an ultrasensitive in vitro assay to monitor growth of primary cell cultures with reduced mitotic activity. J. Immunol. Methods 211:159-169; 1998.
2. Chaudhari, U.; Romano, P.; Mulcahy, L. D.; Dooley, L. T.; Baker, D. G.; Gottlieb, A. B. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet 357:1842-1847; 2001.
3. Chen, Y. R.; Tan, T. H. Inhibition of the c-jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 17:173-178; 1998.
4. Cheng, A. L.; Hsu, C. H.; Lin, J. K., et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21:2895-2900; 2001.
5. Dengler, W. A.; Schulte, J.; Berger, D. P.; Mertelsmann, R.; Fiebig, H. H. Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays. Anticancer Drugs 6:522-532; 1995.
6. Dykes, P. J.; Brunt, J.; Marks, R. The effect of cyclosporin on human epidermal keratinocytes in vitro. Br. J. Dermatol. 122:173-180; 1990.
7. Fisher, G. J.; Duell, E. A.; Nickoloff, B. J.; Annesley, T. M.; Kowalke, J. K.; Ellis, C. N.; Voorhees, J. J. Levels of cyclosporin in epidermis of treated psoriasis patients differentially inhibit growth of keratinocytes cultured in serum free versus serum containing media. J. Invest. Dermatol. 91:142-146; 1988.
8. Gottlieb, A. B.; Khandke, L.; Krane, J. F.; Staiano-Coico, L.; Ashinoff, R.; Krueger, J. G. Anthralin decreases keratinocyte TGF-alpha expression and EGF-receptor binding in vitro. J. Invest. Dermatol. 98:680-685; 1992.
9. Ieiri, I.; Nakayama, J.; Murakami, H.; Hori, Y.; Higuchi, S. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis. Int. J. Clin. Pharmacol. Ther. 34:106-111; 1996.
10. Jeffes, E. W., III; Lee, G. C.; Said, S., et al. Elevated numbers of proliferating mononuclear cells in the peripheral blood of psoriatic patients correlate with disease severity. J. Invest. Dermatol. 105:733-738; 1995a.
11. Jeffes, E. W., III; McCullough, J. L.; Pittelkow, M. R., et al. Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate. J. Invest. Dermatol. 104:183-188; 1995b.
12. Katayama, H.; Kawada, A. Exacerbation of psoriasis induced by indomethacin. J. Dermatol. 8:323-327; 1981.
13. Konger, R. L.; Malaviya, R.; Pentland, A. P. Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes. Biochim. Biophys. Acta 1401:221-234; 1998.
14. Lee, J. C.; Laydon, J. T.; McDonnell, P. C., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746; 1994.
15. Mukhopadhyay, A.; Bueso-Ramos, C.; Chatterjee, D.; Pantazis, P.; Aggarwal, B. B. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 20:7597-7609; 2001.
16. Nakamura, K.; Yasunaga, Y.; Segawa, T.; Ko, D.; Moul, J. W.; Srivastava S.; Rhim, J. S. Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int. J. Oncol. 21:825-830; 2002.
17. Nickoloff, B. J.; Fisher, G. J.; Mitra, R. S.; Voorhees, J. J. Additive and synergistic antiproliferative effects of cyclosporin A and gamma interferon on cultured human keratinocytes. Am. J. Pathol. 131:12-18; 1988.
18. Pentland, A. P.; Needleman, P. Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J. Clin. Invest. 77:246-251; 1986.
19. Pfundt, R.; Wingens, M.; Bergers, M.; Zweers, M.; Frenken, M.; Schalkwijk, J. TNF-alpha and serum induce SKALP/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway. Arch. Dermatol. Res. 292:180-187; 2000.
20. Pol, A.; Bergers, M.; van Ruissen, F.; Pfundt, R.; Schalkwijk, J. A simple technique for high-throughput screening of drugs that modulate normal and psoriasis-like differentiation in cultured human keratinocytes. Skin Pharmacol. Appl. Skin Physiol. 15:252-261; 2000.
21. Schwartz, P. M.; Kugelman, L. C.; Coifman, Y.; Hough, L. M.; Milstone, L. M. Human keratinocytes catabolize thymidine. J. Invest. Dermatol. 90:8-12; 1988.
22. Sharpe, G. R.; Fisher, C. Time-dependent inhibition of growth of human keratinocytes and fibroblasts by cyclosporin A: effect on keratinocytes at therapeutic blood levels. Br. J. Dermatol. 123:207-213; 1990.
23. Sorensen, S.; Solvsten, H.; Politi, Y.; Kragballe, K. Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: modulation by ligands for retinoic acid and retinoid X receptors. Skin Pharmacol. 10:144-152; 1997.
24. van Ruissen, F.; de Jongh, G. J.; Zeeuwen, P. L.; van Erp, P. E.; Madsen, P.; Schalkwijk, J. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures. J. Cell. Physiol. 168:442-452; 1996.
25. Varam, J.; Nickoloff, B. J.; Dixit, V. M.; Mitra, R. S.; Voorhees, J. J. All-trans retinoic acid stimulates growth of adult human keratinocytes cultured in growth factor-deficient medium, inhibits production of thrombospondin and fibronectin, and reduces adhesion. J. Invest. Dermatol. 93:449-454; 1989.